Patients Choice Laboratories (PCL), a leading provider of comprehensive laboratory testing throughout the United States, announced today that it has acquired Infinity Laboratories, LLC located in Bridgeport, Texas for an undisclosed price. According to the LevinPro HC database, this marks the 106th transaction in the Laboratories, MRI and Dialysis sector this year, and the 59th deal in the diagnostics subsector.
The acquisition will provide PCL a location in the southern United States to bring their complete suite of testing services to the area. Patients Choice Laboratories plans to begin running tests out of the newly acquired Bridgeport, Texas location in the coming weeks.
Founded in 1991, Infinity Laboratories is an infectious disease laboratory specializing in molecular diagnostics serving the population of north Texas.
Patients Choice Laboratories (PCL) is a CLIA certified and CAP accredited laboratory based in Indianapolis, Indiana. PCL specializes in infectious disease, pharmacogenetics, blood work and toxicology. Utilizing industry-leading molecular diagnostics, PCL provides precise and specific results allowing for quick diagnoses and treatment of patients within 24-hours.
